Subscribe to Snippets

Navigating the patent thicket – “IP in 5” video series

  • Kevin E. Noonan Christopher P. Singer, Ph.D.
  • March 24, 2025
  • Snippets

Practices & Technologies

Biotechnology & Pharmaceuticals

In the “IP in 5” video series, MBHB Partners Kevin Noonan and Chris Singer discuss the role of patents in drug development and allegations that patents are being used to create complex “thickets.”

AI News Roundup – OpenAI and FDA discussing AI for drug approval, AI chatbots fuel wave of cheating at U.S. colleges, AI bots flood internet with “slop,” and more

MBHB Partner Mike Borella on the Federal Circuit and AI Patent Eligibility

AI News Roundup – Los Angeles ramps up use of AI-assisted cameras to issue traffic tickets, Google launches AI-based language learning tools, Generative AI in video games, and more

About the Authors

Kevin E. Noonan

Kevin E. Noonan is co-Chair of MBHB’s Biotechnology and Pharmaceuticals Practice Group. Dr. Noonan is an experienced patent lawyer, molecular biologist and renowned thought leader in biotechnology and pharmaceutical patent law. Over the past 30 years, he has counseled some of the largest biotechnology and pharmaceutical companies in the world on intellectual property issues.

Christopher P. Singer, Ph.D.

Christopher Singer, Ph.D.is engaged by clients in the life sciences industry for his experience with domestic and foreign patent prosecution, due diligence, strategic counseling, patent portfolio management, and opinion work. Dr. Singer works with individual inventors, emerging companies, national universities and global biotechnology and pharmaceutical companies.
© 2025 McDonnell Boehnen Hulbert & Berghoff LLP snippets is a trademark of McDonnell Boehnen Hulbert & Berghoff LLP. All rights reserved. The information contained in this newsletter reflects the understanding and opinions of the author(s) and is provided to you for informational purposes only. It is not intended to and does not represent legal advice. MBHB LLP does not intend to create an attorney–client relationship by providing this information to you. The information in this publication is not a substitute for obtaining legal advice from an attorney licensed in your particular state. snippets may be considered attorney advertising in some states.
PrevPrevious PostAI News Roundup – DOGE testing chatbot for civil service, DeepMind unveils robotics-focused AI models, Spain proposes massive fines for violating AI disclosure rules, and more
Next PostAI News Roundup – U.S. appeals court affirms that wholly AI-generated content is not eligible for copyright protection, California panel recommends further AI regulations, and moreNext
  • contact us
  • client pay
  • privacy policy
  • disclaimer
Youtube Linkedin-in
  • © 2025 McDonnell Boehnen Hulbert & Berghoff LLP
Search
Menu
People
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Services
Practices Technologies
Intelligence
NewsEventsSnippetsPatently-O BlogPatent Docs
Firm
Diversity & InclusionCommunityAwards & AccoladesOur Clients
Careers
Culture and Development Career Paths Diversity And Inclusion Legal Professionals Business Professionals
LocationContact Us
Client Pay
Menu